• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于皮肤给药的囊泡载体。

Vesicular carriers for dermal drug delivery.

作者信息

Sinico Chiara, Fadda Anna Maria

机构信息

University of Cagliari, Dipartimento Farmaco Chimico Tecnologico, 09124 Cagliari -Italy.

出版信息

Expert Opin Drug Deliv. 2009 Aug;6(8):813-25. doi: 10.1517/17425240903071029.

DOI:10.1517/17425240903071029
PMID:19569979
Abstract

The skin can offer several advantages as a route of drug administration although its barrier nature makes it difficult for most drugs to penetrate into and permeate through it. During the past decades there has been a lot of interest in lipid vesicles as a tool to improve drug topical delivery. Vesicular systems such as liposomes, niosomes, ethosomes and elastic, deformable vesicles provide an alternative for improved skin drug delivery. The function of vesicles as topical delivery systems is controversial with variable effects being reported in relation to the type of vesicles and their composition. In fact, vesicles can act as drug carriers controlling active release; they can provide a localized depot in the skin for dermally active compounds and enhance transdermal drug delivery. A wide variety of lipids and surfactants can be used to prepare vesicles, which are commonly composed of phospholipids (liposomes) or non-ionic surfactants (niosomes). Vesicle composition and preparation method influence their physicochemical properties (size, charge, lamellarity, thermodynamic state, deformability) and therefore their efficacy as drug delivery systems. A review of vesicle value in localizing drugs within the skin at the site of action will be provided with emphasis on their potential mechanism of action.

摘要

尽管皮肤的屏障特性使得大多数药物难以渗透进入和透过,但作为给药途径,皮肤具有若干优势。在过去几十年中,脂质囊泡作为改善药物局部递送的工具受到了广泛关注。脂质体、非离子型脂质体、醇质体和弹性可变形囊泡等囊泡系统为改善皮肤药物递送提供了一种替代方法。囊泡作为局部递送系统的功能存在争议,关于囊泡类型及其组成的报道显示出不同的效果。事实上,囊泡可作为控制药物活性释放的载体;它们可为皮肤活性化合物在皮肤中提供局部储库,并增强透皮药物递送。多种脂质和表面活性剂可用于制备囊泡,囊泡通常由磷脂(脂质体)或非离子表面活性剂(非离子型脂质体)组成。囊泡的组成和制备方法会影响其物理化学性质(大小、电荷、层数、热力学状态、可变形性),进而影响其作为药物递送系统的功效。本文将综述囊泡在将药物定位在皮肤作用部位方面的价值,并重点阐述其潜在作用机制。

相似文献

1
Vesicular carriers for dermal drug delivery.用于皮肤给药的囊泡载体。
Expert Opin Drug Deliv. 2009 Aug;6(8):813-25. doi: 10.1517/17425240903071029.
2
Vesicles as tools for the modulation of skin permeability.囊泡作为调节皮肤渗透性的工具。
Expert Opin Drug Deliv. 2007 Nov;4(6):579-93. doi: 10.1517/17425247.4.6.579.
3
Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.尼奥斯体作为维甲酸的载体。III. 对囊泡包裹维甲酸的体外皮肤给药研究。
Int J Pharm. 2006 Mar 27;311(1-2):11-9. doi: 10.1016/j.ijpharm.2005.11.045. Epub 2006 Jan 24.
4
Liposomes and skin: from drug delivery to model membranes.脂质体与皮肤:从药物递送 to 模型膜
Eur J Pharm Sci. 2008 Aug 7;34(4-5):203-22. doi: 10.1016/j.ejps.2008.05.002. Epub 2008 May 8.
5
Liposomes and niosomes as topical drug delivery systems.脂质体和非离子表面活性剂泡囊作为局部给药系统。
Skin Pharmacol Physiol. 2005 Sep-Oct;18(5):209-19. doi: 10.1159/000086666. Epub 2005 Jul 5.
6
Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.局部脂质体中的他莫昔芬:研发、表征及体外评价
J Pharm Pharm Sci. 2004 Jul 16;7(2):252-9.
7
Lipid vesicles for skin delivery of drugs: reviewing three decades of research.用于皮肤给药的脂质囊泡:三十年研究综述
Int J Pharm. 2007 Mar 6;332(1-2):1-16. doi: 10.1016/j.ijpharm.2006.12.005. Epub 2006 Dec 8.
8
Can drug-bearing liposomes penetrate intact skin?载药脂质体能否穿透完整皮肤?
J Pharm Pharmacol. 2006 Apr;58(4):415-29. doi: 10.1211/jpp.58.4.0001.
9
Deformable liposomes and ethosomes: mechanism of enhanced skin delivery.可变形脂质体与醇质体:增强皮肤给药的机制
Int J Pharm. 2006 Sep 28;322(1-2):60-6. doi: 10.1016/j.ijpharm.2006.05.027. Epub 2006 May 19.
10
What's new in the field of phospholipid vesicular nanocarriers for skin drug delivery.磷脂囊泡纳米载体在皮肤药物传递领域的新进展。
Int J Pharm. 2020 Jun 15;583:119398. doi: 10.1016/j.ijpharm.2020.119398. Epub 2020 May 4.

引用本文的文献

1
Nanocarriers in Ungual Drug Delivery.用于指甲给药的纳米载体。
Pharmaceutics. 2025 Aug 15;17(8):1060. doi: 10.3390/pharmaceutics17081060.
2
Liposomal Nanocarriers to Enhance Skin Delivery of Chemotherapeutics in Cancer Therapy.用于增强癌症治疗中化疗药物皮肤递送的脂质体纳米载体
Bioengineering (Basel). 2025 Jan 30;12(2):133. doi: 10.3390/bioengineering12020133.
3
Beyond Skin Deep: Phospholipid-Based Nanovesicles as Game-Changers in Transdermal Drug Delivery.超越皮肤的局限:基于磷脂的纳米囊泡在经皮药物传递中的变革作用。
AAPS PharmSciTech. 2024 Aug 13;25(6):184. doi: 10.1208/s12249-024-02896-6.
4
Recent Advancements and Trends of Topical Drug Delivery Systems in Psoriasis: A Review and Bibliometric Analysis.近年来银屑病局部给药系统的研究进展及趋势:综述和文献计量分析。
Int J Nanomedicine. 2024 Jul 29;19:7631-7671. doi: 10.2147/IJN.S461514. eCollection 2024.
5
From lab to industrial development of lipid nanocarriers using quality by design approach.从实验室到脂质纳米载体的工业开发:采用质量源于设计方法
Int J Pharm X. 2024 Jul 1;8:100266. doi: 10.1016/j.ijpx.2024.100266. eCollection 2024 Dec.
6
Niosome as a promising tool for increasing the effectiveness of anti-inflammatory compounds.脂质体作为一种提高抗炎化合物有效性的有前景的工具。
EXCLI J. 2024 Feb 7;23:212-263. doi: 10.17179/excli2023-6868. eCollection 2024.
7
Novel Microemulsion Containing Benzocaine and Fusidic Acid Simultaneously: Formulation, Characterization, and In Vitro Evaluation for Wound Healing.新型同时含有苯佐卡因和夫西地酸的微乳:制剂、表征及体外创伤愈合评价。
AAPS PharmSciTech. 2024 Mar 5;25(3):53. doi: 10.1208/s12249-024-02762-5.
8
Nanocrystal Structure of Minoxidil: A Safe Stimulator for Hair Growth Factor for C57BL/6 Mice.米诺地尔的纳米晶体结构:C57BL/6小鼠毛发生长因子的安全刺激剂
Curr Med Chem. 2024 Feb 15. doi: 10.2174/0109298673283413240116065844.
9
Therapeutic Effect of Resveratrol and its Novel Formulations on Lung Cancer: Focus on Biological Aspects and Underlying Pathways.白藜芦醇及其新型制剂治疗肺癌的疗效:聚焦生物学方面及潜在作用机制。
Curr Med Chem. 2024;31(27):4340-4361. doi: 10.2174/0109298673266259231229050937.
10
Enhancing Gene Therapy through Ultradeformable Vesicles for Efficient siRNA Delivery.通过超可变形囊泡增强基因治疗以实现高效的小干扰RNA递送
Pharm Nanotechnol. 2025;13(1):55-69. doi: 10.2174/0122117385271654231215064542.